<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02363413</url>
  </required_header>
  <id_info>
    <org_study_id>VNI_001</org_study_id>
    <nct_id>NCT02363413</nct_id>
  </id_info>
  <brief_title>Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome</brief_title>
  <acronym>OVNI-Dom</acronym>
  <official_title>Initiation of Non- Invasive Ventilation at Home Versus Hospital Among Patients With Overlap Syndrome: Randomized Controlled Non-inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IP Santé Domicile</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IP Santé Domicile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is based on the assumption that in the Overlap Syndrome, the introduction at home
      of the NIV is as effective in terms of compliance and clinical and gazometric improvement,
      and life quality, that setting hospital start up. The investigators will study the initiation
      of NIV at home versus in hospital in two randomized Overlap Syndrome patient groups. The main
      objective of the study is to demonstrate the non-inferiority of the initiation of the NIV at
      home versus hospital in terms of compliance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Overlap Syndrome is defined by the coexistence of chronic obstructive pulmonary disease
      (COPD) and an apnea - hypopnea syndrome obstructive sleep (SAHS). The interaction between
      these two diseases is responsible for deepest nocturnal desaturation, decreased sensitivity
      to CO2, more pronounced sleep alterations, more frequent daytime hypercapnia, a higher risk
      of hypertension pulmonary and increased cardiovascular risk, compared to subjects with COPD
      or isolated SAHS.

      The Overlap Syndrome treatments are continuous positive airway pressure (CPAP) or
      non-invasive ventilation (NIV), associated complemented or not by oxygen therapy during
      sleep. The criteria for choosing the type of treatment are not well defined. Quality and
      compliance of the NIV are very important in all diseases leading to chronic respiratory
      failure whose Overlap Syndrome. The increase in the number of patients treated with NIV is
      estimated at over 12% per year. The NIV startup is usually performed in a conventional
      hospitalization but congestion healthcare pathways lead to increase waiting time before
      treatment. Thus, to date, no study has validated a supported alternative to meet the increase
      in the number of patients on NIV while maintaining quality service.

      The HAS has defined good candidates for a NIV home based startup, on the following criteria:
      patients with a recognized indication of NIV in the long term , with stable respiratory
      failure, requiring only nocturnal ventilation, surrounded by caregivers mastering the use of
      equipment and whose location allows rapid intervention. The study is based on the assumption
      that in the Overlap Syndrome, the introduction at home of the NIV is as effective in terms of
      compliance and clinical and gazometric improvement, and life quality, that setting hospital
      start up. The investigators will study the initiation of NIV at home versus in hospital in
      two randomized Overlap Syndrome patient groups. The main objective of the study is to
      demonstrate the non-inferiority of the initiation of the NIV at home versus hospital in terms
      of compliance.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compliance- average adherence measured over the three months under NIV expressed in hours/night</measure>
    <time_frame>month 3 (M3)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of ventilation : evolution of the pCO2 and nocturnal saturation at M3</measure>
    <time_frame>month 3 (M3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life and satisfaction of the patients : patient life satisfaction questionnaire</measure>
    <time_frame>month 3 (M3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the occurrence of complications : number of NIV complication occurred</measure>
    <time_frame>month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>economic study- number of hospitalization nights</measure>
    <time_frame>month 3 (M3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>economic study- number of intervention of the kinesiologist and the technician</measure>
    <time_frame>month 3 (M3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>economic study- number of phone contact by the patient</measure>
    <time_frame>month 3 (M3)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Overlap Syndrome</condition>
  <arm_group>
    <arm_group_label>IniVAH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Initiation of the NIV in hospital : current care. 3 days hospitalization to start-up the NIV as usual.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IniVAD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Initiation of the NIV at home : experimental care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IniVAH</intervention_name>
    <description>Initiation of the NIV during a 3 days hospitalization as usual.</description>
    <arm_group_label>IniVAH</arm_group_label>
    <other_name>Initiation of the NIV at hospital : current care</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IniVAD</intervention_name>
    <description>Initiation of the NIV at home. The first day, the kinesiologist and the technician start-up the NIV at home with the patient. The investigator will validate the adjustment settings proposed by the kinesiologist. No procedure during the second day as described by the HAS. The third day, the kinesiologist and the technician come back to the patient home so as to adjust the settings if needed and if validated by the investigator.</description>
    <arm_group_label>IniVAD</arm_group_label>
    <other_name>Initiation of the NIV at home</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patients, of less than 80 years

          -  Patients with chronic respiratory failure within a Overlap syndrome ( defined by the
             coexistence of COPD and OAS ) in stable situation (no exacerbation for at least 4
             weeks) , indication for a NIV treatment

          -  OAS confirmed by polysomnography according to the standards of the American Academy of
             Sleep Medicine ( AASM ) with an AHI&gt; 15, the central apneas are tolerated if &lt; 20%

          -  COPD defined by obstruction of the air flow : VEMS/CVF &lt;70 % and VEMS &lt;80% of the
             average value predicted

          -  Started criteria of NIV: chronic respiratory failure within an Overlap Syndrome and
             PaCO2 &gt; 45 mmHg (at rest on room air ) and / or medium PtCO2 &gt; 50 mmHg

          -  Patient informed of the study and who signed an informed consent

        Exclusion Criteria:

          -  Patients already treated for OAS in the year

          -  Patient tracheotomised

          -  Other diseases with respiratory involvement : neuromuscular disease , restrictive
             disease of the chest with CPT &lt;80% , apnea syndrome pure central sleep ( central apnea
             are tolerated if &lt; 20% )

          -  Lung cancer within the last 5 years

          -  Uncontrolled psychic diseases

          -  Acute respiratory failure requiring NIV , going back a month

          -  Clinical situation requiring prolonged hospitalization

          -  Patients with no opportunity to understand and follow instructions

          -  Refusal to participate in the study

          -  Lack of insurance coverage

          -  Pregnant and / or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Safia Maaradji-Gati, MD</last_name>
    <role>Study Director</role>
    <affiliation>IPSanté Domicile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jésus Gonzalez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>La Pitié-Salpétrière</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Pia D'orthor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Bichat - Claude Bernard</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Géraldine Boy, PhD</last_name>
    <phone>0607434961</phone>
    <email>geraldine.boy@ipsante.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Safia Maaradji-Gati, MD</last_name>
    <phone>0674038420</phone>
    <email>safia.maaradji-Gati@ipsante.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Annecy-Genevois</name>
      <address>
        <city>Annecy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Taoufik DIDI, MD</last_name>
      <phone>04 50 63 66 03</phone>
      <email>tdidi@ch-annecygenevois.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Chirurgicale Bel-Air</name>
      <address>
        <city>Bordeaux</city>
        <zip>33073</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie RAYMOND, MD</last_name>
      <phone>05 56 73 11 64</phone>
      <email>drraymond.nathalie@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06401</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe PERRIN, MD</last_name>
      <phone>06 79 57 51 33</phone>
      <email>C.PERRIN@ch-cannes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudio RABEC, MD</last_name>
      <phone>06 62 28 11 92</phone>
      <email>claudio.rabec@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Intercommunal du Val d'Ariège</name>
      <address>
        <city>Foix</city>
        <zip>09017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abdelkader GHAZI, MD</last_name>
      <phone>05 61 03 31 30</phone>
      <email>abdelkader.ghazi@chi-val-ariege.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Raymond Poincaré</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David ORLIKOWSKI, MD</last_name>
      <phone>01 47 10 77 52</phone>
      <email>david.orlikowski@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble site Nord - Hôpital Albert Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-louis PEPIN, MD</last_name>
      <phone>04 76 76 92 65</phone>
      <email>JPepin@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Haguenau</name>
      <address>
        <city>Haguenau</city>
        <zip>67500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Parisa ASSEMI, MD</last_name>
      <phone>03 88 06 33 33</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Du Blanc Mesnil</name>
      <address>
        <city>le Blanc Mesnil</city>
        <zip>93150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naim FOURAR, MD</last_name>
      <phone>06 50 60 16 69</phone>
      <email>naimfourar@hotmail.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste du Medoc</name>
      <address>
        <city>Lesparre</city>
        <zip>33340</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie RAYMOND, MD</last_name>
      <phone>05 56 73 11 64</phone>
      <email>drraymond.nathalie@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHR - Hôpital Calmette</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphanie FRY, MD</last_name>
      <phone>03 20 44 5948</phone>
      <email>Stephanie.POUWELS@CHRU-LILLE.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Pia d'ORTHO, MD</last_name>
      <phone>01 40 25 84 01</phone>
      <email>marie-pia.dortho@bch.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU La Pitié-salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jésus GONZALEZ, MD</last_name>
      <phone>06 65 63 59 36</phone>
      <email>jesus.gonzalez@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jésus Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Laurent</name>
      <address>
        <city>Rennes</city>
        <zip>35700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud PRIGENT, MD</last_name>
      <phone>02 99 38 33 69</phone>
      <email>prigent@icloud.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Arnault Tzanck</name>
      <address>
        <city>Saint Laurent du Var</city>
        <zip>06721</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guy-René BOYER, MD</last_name>
      <phone>04 92 27 38 72</phone>
      <email>guyboyer@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Strasbourg - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Romain KESSLER, MD</last_name>
      <phone>06 60 27 48 90</phone>
      <email>romain.kessler@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Larrey CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31053</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kamila SEDKAOUI, MD</last_name>
      <phone>05 67 77 18 32</phone>
      <email>sedkaoui.k@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2015</study_first_submitted>
  <study_first_submitted_qc>February 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2015</study_first_posted>
  <last_update_submitted>August 5, 2015</last_update_submitted>
  <last_update_submitted_qc>August 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NIV</keyword>
  <keyword>Overlap Syndrom</keyword>
  <keyword>home</keyword>
  <keyword>hospital</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

